Phase 2a study of AR-12286 for treatment of glaucoma and ocular hypertension - MPR
Links shared publicly online about this topic.
- 1,658total visits
Phase 2a study of AR-12286 for treatment of glaucoma and ocular hypertension - MPR
empr.com —
Aerie Pharmaceuticals announced positive results from a Phase 2a study of AR-12286 for the treatment of primary open angle glaucoma or ocular hypertension.
View full resource at empr.com
Tags: Heart Disease, High Blood Pressure, Glaucoma, Pharma, News
Most Recently Shared on October 22, 2009 at 3:15 pm By:
MPR News: Phase 2a study of AR-12286 for treatment of glaucoma and ocular hypertension: Aerie Pharmace.. http://bit.ly/3X4itl
Advertisement
